Joined Today: 1

NYMX Nymox Pharmaceutical Corporation, Stock Message Board

All Messages

NYMX Message Board Home | Join The NYMX Group |

#85: NYMX Stock News : Nymox Announces Dosing of First Patient in Phase 3 Trial for NX-1207 for BPH
TheMachine	June 4, 2009 10:18:32 AM
HASBROUCK HEIGHTS, N.J., June 2, 2009 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) today announced the dosing of the first patient in the Company's NX02-0017 multi-center, ... view message ignore post recommend post

#84: Statins Reduce Risk of Alzheimer's Disease According to New Long-Term Prospective Study
TheMachine	October 20, 2008 12:16:40 PM
Nymox (NASDAQ:NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease Nymox Pharmaceutical Corporation (NASDAQ:NYMX)... view message ignore post recommend post

#83: Nymox Announces Clinical Study Presentation on BPH Drug at American Urological Association Meeting
Stock News Bot	April 21, 2008 10:40:58 AM
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that new clinical trial data concerning the safety and efficacy of the Company’s NX-1207 for benign prostatic... view message ignore post recommend post

#82: Nymox Reports Completion of Large New 2 Year Follow-up Study of NX-1207 for BPH
FastFun	December 1, 2007 06:47:04 PM
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today completion of a large new 2 year follow-up study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated... view message ignore post recommend post

#81: NYMX News Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
Stock News Bot	March 19, 2007 06:30:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced positive results from its newly completed long-term outcome study of NX-1207 for... view message ignore post recommend post

#80: NYMX News Nymox Reports 2006 Financial Results
Stock News Bot	March 15, 2007 06:30:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the year ended December 31, 2006. Product sales... view message ignore post recommend post

#79: NYMX News Nymox Reports Completion of New Long-term Study of NX-1207 for BPH
Stock News Bot	February 28, 2007 08:44:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today completion of a new long-term follow-up study of NX-1207 for benign prostatic... view message ignore post recommend post

#78: NYMX News Nymox Protein Biomarker for Alzheimer's is Years Ahead of Competition
Stock News Bot	December 13, 2006 08:22:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation’s (NASDAQ:NYMX) AlzheimAlert™ test is literally years ahead of the competition, according to... view message ignore post recommend post

#77: NYMX News Nymox NXC-4720 Reduces E. Coli Contamination By 99%
Stock News Bot	December 12, 2006 07:09:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is developing is developing NXC-4720, the Company’s innovative new product targeting E.... view message ignore post recommend post

#76: NYMX News Nymox Announces $13 Million Equity Financing
Stock News Bot	November 29, 2006 11:15:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company has secured new commitment for $13 million in private equity ... view message ignore post recommend post

#75: NYMX News Newly Published Editorial in Expert Opinion on Investigational Drugs Says Statins May Be Good for Alzheimer's Disease
Stock News Bot	November 22, 2006 07:00:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--A newly published editorial in Expert Opinion on Investigational Drugs has concluded that statins, the widely used cholesterol drugs,... view message ignore post recommend post

#74: NYMX News Nymox Pursuing New Approaches to an Old Disease
Stock News Bot	November 20, 2006 09:12:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is taking innovative and unique approaches to the diagnosis and treatment of Alzheimer's disease. ... view message ignore post recommend post

#73: NYMX News Nymox Product a Tool for Smoking Cessation Efforts
Stock News Bot	November 17, 2006 09:39:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--November 16 is the American Cancer Society’s Great American Smokeout, when smokers across the U.S. are encouraged to butt out for the... view message ignore post recommend post

#72: NYMX News Nymox Reports Third Quarter 2006 Financial Results
Stock News Bot	November 13, 2006 07:01:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the third quarter of 2006. Nymox reported a net ... view message ignore post recommend post

#71: NYMX News Statin Drugs Gain Traction as Potential Treatment for Alzheimer's Disease
Stock News Bot	November 10, 2006 09:48:00 AM
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Statins, the widely used cholesterol drugs with a global market over $25 billion, are gaining wide attention as a potential new way of treating ... view message ignore post recommend post

Group Home | Login if you want to post a message